Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current Assets    
Cash and cash equivalents $ 2,177,072 $ 3,672,877
Marketable securities 16,165 15,731
Restricted cash 555,187 555,008
Accounts receivable - project revenue and reimbursable project costs 507,738 425,916
Prepaid expenses & other current assets 461,876 288,939
Total Current Assets 3,718,038 4,958,471
Property Plant and Equipment -net 0 0
Other Assets    
Patent costs - net 725,588 699,168
Total Assets 4,443,626 5,657,639
Current Liabilities    
Accounts payable and accrued liabilities 636,742 476,628
Total Current Liabilities 636,742 476,628
Commitments and contingencies      
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding 0 0
Common stock, $0.001 par value, 500,000,000 authorized, 15,064,069 shares outstanding and 15,057,243 shares outstanding at March 31, 2014 and December 31, 2013, respectively 15,064 15,057
Additional paid in capital - stock and stock equivalents 76,303,552 76,243,764
Deficit (72,511,732) (71,077,810)
Total Stockholders' Equity 3,806,884 5,181,011
Total Liabilities and Stockholders' Equity $ 4,443,626 $ 5,657,639